SAG
DNA icon

SageView Advisory Group’s Ginkgo Bioworks DNA Stock Holding History

SageView Advisory Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12
Closed -$100 – 1071
2025
Q4 		$100 Buy
+12
New +$129 ﹤0.01% 2542
2024
Q2 		– Sell
-164
Closed -$481K – 580
2024
Q1 		$481K Buy
+164
New +$8.49K 0.02% 331

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SageView Advisory Group's DNA Position: Q1 2026 in Review

SageView Advisory Group sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 12 shares — an estimated $100 sold.

SageView Advisory Group first reported a position in DNA in Q1 2024 and held it in 2 quarters. The position peaked at $481K in Q1 2024. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • SageView Advisory Group reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 12 Ginkgo Bioworks shares in Q1 2026, an estimated $100.
  • SageView Advisory Group first reported a position in Ginkgo Bioworks in Q1 2024 and held it in 2 quarters.
  • SageView Advisory Group's Ginkgo Bioworks position peaked at $481K in Q1 2024.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.